WOMEN 'S HEALTH AND MENOPAUSE : - National Heart, Lung ...

63 MacGillivray MH, Morishima A, Conte F, Grumbach
M, Smith EP. Pediatric endocrinology update: an
overview. The essential roles of estrogens in pubertal
growth, epiphyseal fusion and bone turnover:
lessons from mutations in the genes for aromatase
and the estrogen receptor. Horm Res
1998;49(3)(Suppl 1):2–8.
64 Couse JF, Korach KS. Estrogen receptor null mice:
what have we learned and where will they lead us?
Endocr Rev 1999;20:358–417.
65 Cunha GR, Young P, Hom YK, Cooke PS, Taylor JA,
Lubahn DB. Elucidation of a role for stromal
steroid hormone receptors in mammary gland
growth and development using tissue recombinants.
J Mammary Gland Biol Neoplasia
1997;2(4):393–402.
66 Leygue E, Dotzlaw H, Watson PH, Murphy LC.
Expression of estrogen receptor beta1, beta2, and
beta5 messenger RNAs in human breast tissue.
Cancer Res 1999;59(6):1175–9.
67 Saji S, Jensen EV, Nilsson S, Rylander T, Warner M,
Gustafsson J-Å. Estrogen receptors alpha and beta
in the rodent mammary gland. Proc Natl Acad Sci
USA 2000;97(1):337–42.
68 Speirs V, Parkes AT, Kerin MJ, et al. Coexpression of
estrogen receptor-alpha and -beta: poor prognostic
factors in human breast cancer? Cancer Res
1999;59(3):525–8.
69 Fisher CR, Graves KH, Parlow AF, Simpson ER.
Characterization of mice deficient in aromatase
(ArKO) because of targeted disruption of the cyp19
gene. Proc Natl Acad Sci USA
1998;95(12):6965–70.
70 Smith EP, Boyd J, Frank GR, et al. Estrogen resistance
caused by a mutation in the estrogen-receptor
gene in a man. N Engl J Med
1994;331(16):1056–61.
71 Robertson KM, O’Donnell L, Jones ME, et al.
Impairment of spermatogenesis in mice lacking a
functional aromatase (cyp 19) gene. Proc Natl
Acad Sci USA 1999;96(14):7986–91.
72 Couse JF, Bunch DO, Lindzey J, Schomberg DW,
Korach KS. Prevention of the polycystic ovarian
phenotype and characterization of ovulatory capacity
in the estrogen receptor-alpha knockout mouse.
Endocrinology 1999;140(12):5855–65.
73 Mäkelä S, Strauss L, Kuiper G, et al. Differential
expression of estrogen receptors alpha and beta in
adult rat accessory sex glands and lower urinary
tract [corrected and republished from Mol Cell
Endocrinol 2000;164(1-2):109–16. Mol Cell
Endocrinol 2000;170(1-2):217–29].
74 Chang WY, Prins GS. Estrogen receptor-beta: implications
for the prostate gland. Prostate 1999;
40(2):115–24.
75 Weihua Z, Mäkelä S, Andersson LC, et al. A role for
estrogen receptor beta in the regulation of growth
of the ventral prostate. Proc Natl Acad Sci USA
2001;98(11):6330–5.
76 Prins GS, Marmer M, Woodham C, et al. Estrogen
receptor-beta messenger ribonucleic acid ontogeny
in the prostate of normal and neonatally estrogenized
rats. Endocrinology 1998;139(3):874–83.
77 Lindsay R, Hart DM, Aitken JM, MacDonald EB,
Anderson JB, Clarke AC. Long-term prevention
of postmenopausal osteoporosis by oestrogen.
Evidence for an increased bone mass after delayed
onset of oestrogen treatment. Lancet
1976;1(7968):1038–41.
78 Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black
D, Cummings SR. Estrogen replacement therapy
and fractures in older women. Study of
Osteoporotic Fractures Research Group. Ann Intern
Med 1995;122(1):9–16.
79 Slemenda CW, Longcope C, Zhou L, Hui SL,
Peacock M, Johnston CC. Sex steroids and bone
mass in older men. Positive associations with
serum estrogens and negative associations with
androgens. J Clin Invest 1997;100(7):1755–9.
80 Barrett-Connor E, Mueller JE, von Muhlen DG,
Laughlin GA, Schneider DL, Sartoris DJ. Low
levels of estradiol are associated with vertebral
fractures in older men, but not women: the Rancho
Bernardo study. J Clin Endocrinol Metab
2000;85(1):219–23.
81 Komm BS, Terpening CM, Benz DJ, et al. Estrogen
binding, receptor mRNA, and biological response
in osteoblast-like osteosarcoma cells. Science
1988;241(4861):81–4.
82 Eriksen EF, Colvard DS, Berg NJ, et al. Evidence of
estrogen receptors in normal human osteoblast-like
cells. Science 1988;241(4861):84–6.
97